Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 05 Feb 2026 for Aclaris Therapeutics, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Hugh M. Davis: trading record in brief
Hugh M. Davis appears in our data through filings on Aclaris Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 2 December 2025 to 3 February 2026, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 5 February 2026: an option exercise, in Aclaris Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Hugh M. Davis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
18,675 sharesCommon StockSEC:0002045027-26-000002:0
26,750 sharesCommon StockSEC:0002045027-25-000003:0
2 of 2 declarations
